Pneumonia in the Newborn

Total Page:16

File Type:pdf, Size:1020Kb

Pneumonia in the Newborn Indian J Pediatr 1987; 54 : 199-204 Pneumonia in the newborn O.N. Bhakoo Department of Pediatrics, Postgraduate Institute of Medical Education and Researeh, Chandigarh The studies reviewed in this paper have been made in India on babies looked after in hospital as indoor patients during the first four weeks of life. Some of the studies on hospital-born babies have the advantage of availability of detailed and accurate peri- natal history, closer observation and more definitive diagnosis. An attempt has been made to highlight the results of prospective studies. Understandably, this report is based on relatively more serious cases, who possibly couM not be looked after at home. Key words : Neonatal pneumonia Pneumonia during the neonatal period were most frequently encountered. In can be broadly classified under the follow- the only study in which congenital pne- ing headings. umonia was separately analysed, it was Congenital pneumonia. Most of them found to be commoner than pneumonia present during the first 72 hours of life. due to cross infection. 8 Since in these studies all the babies had not been followed Asph'ation pneumonia. It is mostly till the age of four weeks, the incidence due to aspiration of meconium-stained of pneumonia due to cross infection has liquor at birth or of feeds later on. probably been underestimated. Cross infection pneumonia. This is related to inadequate asepsis. Epidemiology Incidence The common predisposing factors asso- Aatopsy analysis among Indian studies ciated with neonatal pneumonia are showed that 26-0 to 34-6~o of all neonatal low birth weight (LBW), prematurity; deaths in the hospital were associated birth asphyxia, meconeum stained liquor; with pneumonia. 1-4 Reports on clinical duration of labour more than 24 hours; incidence of pneumonia during the neo- maternal fever during labour and delivery; natal period among hospital born babies prolonged rupture of membranes (PROM); have been summarised in Table I. foul smelling liquor; unclean vaginal Pneumonia occurred among 1.5-4.6% examinations (UVE) and baby on assisted of all live births. Aspiration pneumonias ventilation. Lower the weight of the baby, higher are his chances to develop infection. Reprint requests : Dr. O.N. Bhakoo, Professor of Pediatrics, Postgraduate Institute of Medical This vulnerability further increases in Education and Research, Chandigarh 160012. preterm or small-for-dates babies due to 199 200 THE INDIAN JOURNAL OF PEDIATRICS Vol. 54, No. 2 their poor immunological status. Pro- foul smelling liquor, unclean vaginal exa- longed rupture of membranes especially minations and prolonged labour have not if associated with prolonged labour and/ been evaluated in majority of the studies. or birth asphyxia leads to fetal infection Pneumonia may also occur during the and pneumonia. Vaginal examinations, course of septicemia any time during the without the use of gloves and other aseptic neonatal period. It may complicate hyaline measures, are frequently done by the membrane diseases. Infants requiring traditional birth attendants. Babies born endotracheal intubation and IPPR or to such mothers have been found to have ventilator care are at risk to develop higher incidence of infection and pneu- secondary pneumonia. However, of all monia during early neonatal period. 9 The predisposing factors, aspiration is the most relative incidence of different predis- common initiating pathogenetic mecha- posing factors as reportedin studies from nism. Infants vulnerable to aspiration our country has been described in Table II. are those having difficulty in swallowing It is surprising to note that some of the due to prematurity, birth asphyxia, illness important factors like maternal pyrexia, or congenital malformations like cleft Table 1. Incidence of neonatal pneumonia (%of live births) Place of study Chandigarh5 Lucknow6 New Delhi r Rourkela s (1984) (1985) (1981) (1980) Overall incidence 1" 7 1" 8 4" 6 1" 5 Meconium aspiration 1" 1 0" 6 I. 0 Excluded Other types of aspiration 0" 2 0" 5 ? 0" 1 Congenital pneumonia 0" 4 0" 7 3" 6 1" 1 Cross infection pneumonia 0.3 Table II. Epidemiology of neonatal pneumonia (~ of cases in whom factor was operating) Rourekela8 Chandigarh '~ New Delhi7 Lucknow6 Hydera- badt0 LBW (~.~2.5 kg) 37* 81 -- -- 70 Preterm 32 67 45 -- -- PROM 30 -- 26 -- -- Birth asphyxia 48 46 -- -- -- Mec. st. liquor Excluded 64 23 33 -- *Birth weight below 2.0 kg PROM=Premature rupture of membranes, Mec. st.--Meconium stained BHAKO0 : PNEUMONIA IN NEWBORN 2oi palate, macroglossia, glossoptosis eso- were encountered in a sizeable number of phageal atresia etc. cases. Late diagnosis leads to delay in treat- Bacteriology ment, resulting in high mortality. This can be reduced by early diagnosis, which There is only one study on the bacterio- is possible through anticipation and the logy of neonatal pneumonias from our use of rapid diagnostic techniques inclu- country. In this study of lung puncture ding radiology. aspirate of 50 cases of neonatal pneumonia, bacteria were grown from 29 cases. 10 The Anticipation or screening. Neonatal common bacteria grown during the first pneumonia can possibly be anticipated by week were staphylococcus aureus and the use of perinatal risk score 9 and gas- streptococcus while pneumococci were tric aspirates polymorph count at birth.n grown from 14 out of 16 positive cases Perinatal risk score was described by later during neonatal period. Such a us largely to anticipate infection during the preponderance of pneumococcal pneu - first few days of life. 9 Most of the serious monia during neonatal period is an unusual infection thus identified had pneumonia finding and needs confirmation from other as a prominent feature. This score needs centres. The common bacteria grown in to be evaluated for anticipating pneu- the blood culture of cases of neonatal monias occurring during the first three pneumonia at our hospital has been staphy- days of life and may be further simplified lococcus aureus, klebsiella aeruginosa for use by health workers in rural areas. and E coll. 5 No systematic viral studies The score has been described in the on neonatal pneumonia are available appendix. from our country. Table IH. Signs and symptoms in neo- natal pneumonia. ~ Diagnosis Syrup toms Signs and symptoms of neonatal pneu- Lethargy 72 monia are non-specific and vague in a Refusal of feed 46 large number of cases especially in con- Abdominal distension 46 genital pneumonia and among low birth Vomiting 18 Paralytic ileus 16 weight babies. Table III describes the Diarrhea 8 frequency distribution of various signs Umbilical sepsis 32 and symptoms as seen in 50 cases of pneu- Conjunctivitis 10 monia during the neonatal period.10 Signs Tachypnea was seen among only 60~o Taehypnea 60 cases and cough and retractions in only Cyanosis 40 36~o each. Apneic spells were encountered Cough 36 in 28~0. Many signs and symptoms seen Retractions 36 Apneac spells 28 were of non-respiratory nature e.g. lethargy Pulmonary hemorrhage 20 in 72~o, abdominal distension in 46~ and Convulsions 16 refusal to feed in 46~o etc. Again, compli- Meningitis 12 cations like paralytic ileus, pulmonary Note figures denote percentage of cases hemorrhage, convulsions and meningitis 202 THE INDIAN JOURNAL OF PEDIATRICS Vol. 54, No. 2 Gastric aspirate polymorph count done near the four corners and an area at the at birth is a good screening test for diag- centre of the smear. At least 200 cells are nosis of contaminated liquor and possibly counted and the polymorph cells (pus for congenital pneumonia. Lall et al cells) as a percentage of the total cell count have shown it to have a good correlation estimated. A polymorph count of above with early neonatal sepsis.lt The procedure 75~ is indicative of pneumonia and is carried out as follows. below 35~o is considered normal. Poly- The gastric contents should be aspira- morph count between 35-75~o is indeter- ted with sterile catheter and syringe within minate and may suggest possibility of in- one hour of birth. One drop of it fection. This is a quick and a reliable test is taken on a glass slide and mixed with and may be of particular value in our a drop of heparin. The material is spread country where good portable X-ray faci- out and stained with Leishman's stain. lities are not available at many places. The slide is studied under high power Difficulties in diagnosis of pneumonia magnification for polymorph cell count. during the neonatal period are three fold. These cells are counted in ten high power 1. Respiratory symptoms may be present fields and a mean count derived. A mean in the absence of pneumonia. E.g. Hyaline polymorph count of 6 or above is con- membrane disease, transient tachypnea sidered abnormal. Higher the count, more of the newborn, recovery period after is the risk for infection. Gram stain of a perinatal asphyxia, pneumothorax, con- similar smear can give some clue about the genital malformations etc. Differentiation offending bacteria. is possible with the help of history, clini- cal examination and radiology. 2. Differen- Earl), diagnosis of neonatal pneumonia tiation of infectious bronchopneumonia can be made by radiology, gastric aspirate from non infective aspiration pneumonia cytology1: and by some rapid diagnostic can be done from history, gastric aspirate tests like micro ESR, absolute neutrophil cytology and rapid diagnostic tests and count, Band count/Neutrophil count 3. Pneumonia associated with septicemia. ratio and C reactive protein.13,14 More In these cases signs and symptoms are definitive bacteriological diagnosis, which more general and non specific rather than may take 24-48 hours, can be made from related to respiratory tract. Radiology the culture of lung aspirate, blood and and gastric aspirate cytology may help tracheal laryngeal/nesopharangeal secre- in diagnosing pneumonia in such situa- tions. tions.12 It is important to state that the gastric aspirate cytology for diagnosis of neonatal Management pneumonia has to be done differently from that done as a screening test at birth Supportive care is as important as (vide supra)J 2 Here the gastric contents are specific care in determining the outcome aspirated after at least four hours fasting.
Recommended publications
  • Management of Late Preterm and Term Neonates Exposed to Maternal Chorioamnionitis Mitali Sahni1,4* , María E
    Sahni et al. BMC Pediatrics (2019) 19:282 https://doi.org/10.1186/s12887-019-1650-0 RESEARCH ARTICLE Open Access Management of Late Preterm and Term Neonates exposed to maternal Chorioamnionitis Mitali Sahni1,4* , María E. Franco-Fuenmayor2 and Karen Shattuck3 Abstract Background: Chorioamnionitis is a significant risk factor for early-onset neonatal sepsis. However, empiric antibiotic treatment is unnecessary for most asymptomatic newborns exposed to maternal chorioamnionitis (MC). The purpose of this study is to report the outcomes of asymptomatic neonates ≥35 weeks gestational age (GA) exposed to MC, who were managed without routine antibiotic administration and were clinically monitored while following complete blood cell counts (CBCs). Methods: A retrospective chart review was performed on neonates with GA ≥ 35 weeks with MC during calendar year 2013. IT ratio (immature: total neutrophils) was considered suspicious if ≥0.3. The data were analyzed using independent sample T-tests. Results: Among the 275 neonates with MC, 36 received antibiotics for possible sepsis. Twenty-one were treated with antibiotics for > 48 h for clinical signs of infection; only one infant had a positive blood culture. All 21 became symptomatic prior to initiating antibiotics. Six showed worsening of IT ratio. Thus empiric antibiotic administration was safely avoided in 87% of neonates with MC. 81.5% of the neonates had follow-up appointments within a few days and at two weeks of age within the hospital system. There were no readmissions for suspected sepsis. Conclusions: In our patient population, using CBC indices and clinical observation to predict sepsis in neonates with MC appears safe and avoids the unnecessary use of antibiotics.
    [Show full text]
  • Hypotonia and Lethargy in a Two-Day-Old Male Infant Adrienne H
    Hypotonia and Lethargy in a Two-Day-Old Male Infant Adrienne H. Long, MD, PhD,a,b Jennifer G. Fiore, MD,a,b Riaz Gillani, MD,a,b Laurie M. Douglass, MD,c Alan M. Fujii, MD,d Jodi D. Hoffman, MDe A 2-day old term male infant was found to be hypotonic and minimally abstract reactive during routine nursing care in the newborn nursery. At 40 hours of life, he was hypoglycemic and had intermittent desaturations to 70%. His mother had an unremarkable pregnancy and spontaneous vaginal delivery. The mother’s prenatal serology results were negative for infectious risk factors. Apgar scores were 9 at 1 and 5 minutes of life. On day 1 of life, he fed, stooled, and voided well. Our expert panel discusses the differential diagnosis of hypotonia in a neonate, offers diagnostic and management recommendations, and discusses the final diagnosis. DRS LONG, FIORE, AND GILLANI, birth weight was 3.4 kg (56th PEDIATRIC RESIDENTS percentile), length was 52 cm (87th aDepartment of Medicine, Boston Children’s Hospital, d e percentile), and head circumference Boston, Massachusetts; and Neonatology Section, Medical A 2-day old male infant born at Genetics Section, cDivision of Child Neurology, and 38 weeks and 4 days was found to be was 33 cm (12th percentile). His bDepartment of Pediatrics, Boston Medical Center, Boston, limp and minimally reactive during physical examination at birth was Massachusetts routine care in the newborn nursery. normal for gestational age, with Drs Long, Fiore, and Gillani conceptualized, drafted, Just 5 hours before, he had an appropriate neurologic, cardiac, and and edited the manuscript; Drs Douglass, Fujii, and appropriate neurologic status when respiratory components.
    [Show full text]
  • Early-Onset Neonatal Sepsis: a Continuing Problem in Need of Novel Prevention Strategies Barbara J
    Early-Onset Neonatal Sepsis: A Continuing Problem in Need of Novel Prevention Strategies Barbara J. Stoll, MD Early-onset neonatal sepsis (EOS) colonized women or targeted IAP for remains a feared cause of severe women with obstetrical risk factors illness and death among infants of all in labor known to increase GBS birthweights and gestational ages, transmission. 5 Revised guidelines with particular impact among preterm in 2002 recommended universal infants. Centers for Disease Control and antenatal screening for GBS at 35 to Prevention investigators have studied 37 weeks’ gestational age to identify the changing epidemiology of invasive colonized women who should receive EOS for several decades. The Active IAP. 6 Guidelines were additionally Bacterial Core surveillance (ABCs) refined in 2010 to provide neonatal network, a collaboration between management recommendations based the Centers for Disease Control and on maternal risk factors and clinical H. Wayne Hightower Distinguished Professor in the Medical Prevention, state health departments, condition of the infant at birth, with Sciences and Dean, McGovern Medical School, University of and universities, was established in an attempt to reduce unnecessary Texas Health Science Center at Houston, Houston, Texas 1995 to address emerging infectious evaluations of well-appearing infants Opinions expressed in these commentaries are diseases of public health importance, without risk factors. 7 Widespread those of the author and not necessarily those of the including infections due to major adherence to national guidelines American Academy of Pediatrics or its Committees. neonatal pathogens. 1, 2 ABCs data resulted in a remarkable decline DOI: 10.1542/peds.2016-3038 are remarkable because of the in early onset GBS disease, but a Accepted for publication Sep 12, 2016 geographic distribution and size of the concomitant increase in exposure Address correspondence to Barbara J.
    [Show full text]
  • Neonatal Sepsis Expanded Tracking Form Instructions
    2014 ABCs Neonatal Infection Expanded Tracking Form Instruction Sheet Updated 12/19/2013 This form should be completed for all cases of early- and late-onset group B Streptococcus disease (GBS). Early-onset is defined as GBS disease onset at 0-6 days of age [(culture date-birth date) <7 days]. Late-onset is defined as GBS disease at 7-89 days of age [6 days < (culture date-birth date) <90 days]. This case report form for GBS disease can be completed on infants born at home, but not for stillbirths. Additionally, this form should be filled out for all neonatal sepsis cases, which includes both GBS and non-GBS cases. Neonatal sepsis is defined as invasive bacterial disease onset at 0-2 days of age [(culture date-birth date) <3 days]. Case report forms for neonatal sepsis cases should not be completed on infants born at home or stillbirths. For those sites participating in neonatal sepsis surveillance, please refer to the Neonatal Sepsis protocol for clarification on the inclusion and exclusion criteria. The following is an algorithm of which forms should be filled out for early- & late-onset GBS cases meeting the ABCs case definition: FORMS NNS Surveillance Form Neonatal Infection ABCs Case Report Form SCENARIO Expanded Tracking Form* Early-onset (& Neonatal √ √ √ Sepsis)† Late-onset √ √ *The Neonatal Infection Expanded Tracking Form is the expanded form that combines the Neonatal Sepsis Maternal Case Report Form and the Neonatal group B Streptococcus Disease Prevention Tracking Form. † For CA, CT, GA, and MN, please refer to the Neonatal
    [Show full text]
  • Neonatal Pneumonia
    Chapter 2 Neonatal Pneumonia Friedrich Reiterer Additional information is available at the end of the chapter http://dx.doi.org/10.5772/54310 1. Introduction Neonatal pneumonia is a serious respiratory infectious disease caused by a variety of microorganisms, mainly bacteria, with the potential of high mortality and morbidity (1,2). Worldwide neonatal pneumonia is estimated to account for up to 10% of childhood mortality, with the highest case fatality rates reported in developing countries (3,4). It´s impact may be increased in the case of early onset, prematurity or an underlying pulmonary condition like RDS, meconium aspiration or CLD/bronchopulmonary dysplasia (BPD), when the pulmonary capacity is already limited. Ureaplasma pneumonia and ventilator- associated pneumonia (VAP) have also been associated with the development of BPD and poor pulmonary outcome (5,6,7). In this chapter we will review different aspects of neonatal pneumonia and will present case reports from our level III neonatal unit in Graz. 2. Epidemiology Reported frequencies of neonatal pneumonia range from 1 to 35 %, the most commonly quoted figures being 1 percent for term infants and 10 percent for preterm infants (8). The incidence varies according to gestational age, intubation status, diagnostic criteria or case definition, the level and standard of neonatal care, race and socioeconomic status. In a retrospective analysis of a cohort of almost 6000 neonates admitted to our NICU pneumonia was diagnosed in all gestational age classes. The incidence of bacterial pneumonia including Ureaplasma urealyticum (Uu) pneumonia was 1,4 % with a median patient gestational age of 35 weeks (range 23-42 weeks) and a mortality of 2,5%.
    [Show full text]
  • The Effects of Maternal Chorioamnionitis on the Neonate
    Neonatal Nursing Education Brief: The Effects of Maternal Chorioamnionitis on the Neonate https://www.seattlechildrens.org/healthcare- professionals/education/continuing-medical-nursing-education/neonatal- nursing-education-briefs/ Maternal chorioamnionitis is a common condition that can have negative effects on the neonate. The use of broad spectrum antibiotics in labor can reduce the risks, but infants exposed to chorioamnionitis continue to require treatment. The neonatal sepsis risk calculator can guide treatment. NICU, chorioamnionitis, early onset neonatal sepsis, sepsis risk calculator The Effects of Maternal Chorioamnionitis on the Neonate Purpose and Goal: CNEP # 2090 • Understand the effects of chorioamnionitis on the neonate. • Learn about a new approach for treating infants at risk. None of the planners, faculty or content specialists has any conflict of interest or will be presenting any off-label product use. This presentation has no commercial support or sponsorship, nor is it co-sponsored. Requirements for successful completion: • Successfully complete the post-test • Complete the evaluation form Date • December 2018 – December 2020 Learning Objectives • Describe the pathogenesis of maternal chorioamnionitis. • Describe the outcomes for neonates exposed to chorioamnionitis. • Identify 2 approaches for the treatment of early onset sepsis. Introduction • Chorioamnionitis is a common complication • It affects up to 10% of all pregnancies • It is an infection of the amniotic fluid and placenta • It is characterized by inflammation
    [Show full text]
  • Neonatal Sepsis Management Guidelines (PDF)
    Clinical Policy: Neonatal Sepsis Management Reference Number: CP.MP.85 Date of Last Revision: 07/21 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description Through the increased incidence of intra-partum antibiotics, early-onset neonatal sepsis is occurring less frequently. However, it continues to be a common cause of neonatal morbidity and mortality. The CDC (Centers for Disease Control and Prevention) defines early onset sepsis as a blood or cerebrospinal fluid culture-proven infection occurring within the first seven days of life. Group B Streptococcus (GBS) remains the leading cause of neonatal sepsis. More than half of GBS cases occur in infants of mothers with negative GBS cultures, emphasizing the need to remain vigilant for signs of sepsis in all newborns. These infants require comprehensive assessment and treatment, as well as discharge planning, in order to ensure timely treatment in an effort to reduce morbidity and mortality.2 Policy/Criteria It is the policy of Health Plans affiliated with Centene Corporation that the management of neonatal sepsis is medically necessary at the indicated level of care for the following circumstances: I. Episode Day 1 A. Well-appearing infants who are on 48 hours of antibiotics pending blood culture results are appropriate for level II (rev code 172) nursery. B. Symptomatic infants are appropriate for level III (rev code 173) nursery with all the following: 1. Hypotonia, lethargy, or poor oral feeding; 2. Temp ≥ 100.4◦F or ≤ 96.8◦F (≥ 38.0◦ or ≤ 36.0◦C); 3. On 48 hours of antibiotics pending blood culture results or treatment of positive blood cultures.
    [Show full text]
  • Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update
    Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update Aline Fuchsa, Julia Bielickia,b, Shrey Mathurb, Mike Sharlandb, Johannes N. Van Den Ankera,c a Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, Basel, Switzerland b Paediatric Infectious Disease Research Group, Institute for Infection and Immunity, St George's University of London, London, United Kingdom c Division of Clinical Pharmacology, Children’s National Health System, Washington, DC, USA WHO-Reviews 1 TABLE OF CONTENTS 1. INTRODUCTION ............................................................................................................................... 3 1.1. Aims ......................................................................................................................................... 3 1.2. Background ............................................................................................................................. 3 1.2.1. Definition and diagnosis ................................................................................................. 3 Neonatal Sepsis ............................................................................................................................... 3 Paediatric Sepsis ............................................................................................................................. 4 Community versus hospital acquired sepsis .................................................................................. 5 1.2.2. Microbiology ..................................................................................................................
    [Show full text]
  • Best Practices to Addressing Early Onset Neonatal Sepsis Rakhi Gupta Basuray, MD, FAAP Ansley Splinter, MD, Macm, FAAP Objective
    Best Practices to Addressing Early Onset Neonatal Sepsis Rakhi Gupta Basuray, MD, FAAP Ansley Splinter, MD, MAcM, FAAP Objective Apply clinical guidelines for the management of neonates with suspected or proven early onset sepsis Early Onset Sepsis - Defined • Culture-proven, invasive infection, within the first 72 HOL • Mostly due to ascension from normal maternal GI / GU flora • GBS ~40%, E coli ~25% • Current incidence of GBS EOS 0.25/1000 (≥34 weeks GA) • Incidence of all causes of EOS 0.5/1000 Success of Intrapartum Antibiotic Prophylaxis • Since 1995 • 85% decline in GBS EOS, as of 2010 • Used in ~30% of births • No impact on late onset neonatal sepsis 2010 CDC Guidelines • Risk based • Yes/No dichotomous classifications • High weight given to chorioamnionitis • If YES = Antibiotic Treatment MMWR (2010) Vol.59/No.RR-10 2012 AAP Guidelines Evaluation of asymptomatic infants 37 weeks or greater with risk factors for sepsis Polin and the COFN Pediatrics 2012;129:1006-1015 How Well Do Yes/No Risk Factors Perform At Finding Infected Infants? Puopolo KM, et al. Pediatrics. 2011 Nov;128(5):e1155-63 2010 CDC Gaps • Based on EOS incidences 5-10x higher than current • Management guided by risk factors • Chorioamnionitis diagnosis inconsistent • Clinical signs of illness not defined • CBC, CRP interpretations non-standard **200 neonates treated with antibiotics for each episode of EOS** Sepsis Risk Calculator • Puopolo & Escobar • Risk Prediction Tool (2011) • Refined with infant exam findings (2014) • Prospectively validated (2017) https://neonatalsepsiscalculator.kaiserpermanente.org
    [Show full text]
  • Management of Neonates with Suspected Or Proven Early-Onset Bacterial Sepsis
    Guidance for the Clinician in Rendering Pediatric Care CLINICAL REPORT Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis Richard A. Polin, MD and the COMMITTEE ON FETUS AND abstract NEWBORN With improved obstetrical management and evidence-based use of KEY WORDS intrapartum antimicrobial therapy, early-onset neonatal sepsis is be- early-onset sepsis, antimicrobial therapy, group B streptococcus, meningitis, gastric aspirate, tracheal aspirate, chorioamnionitis, coming less frequent. However, early-onset sepsis remains one of the sepsis screen, blood culture, lumbar puncture, urine culture, most common causes of neonatal morbidity and mortality in the pre- body surface cultures, white blood count, acute phase reactants, term population. The identification of neonates at risk for early-onset prevention strategies sepsis is frequently based on a constellation of perinatal risk factors ABBREVIATIONS fi CFU—colony-forming units that are neither sensitive nor speci c. Furthermore, diagnostic tests CRP—C-reactive protein for neonatal sepsis have a poor positive predictive accuracy. As a result, CSF—cerebrospinal fluid clinicians often treat well-appearing infants for extended periods of time, GBS—group B streptococci — even when bacterial cultures are negative. The optimal treatment of I/T immature to total neutrophil (ratio) PMN—polymorphonuclear leukocyte infants with suspected early-onset sepsis is broad-spectrum antimicro- PPROM—preterm premature rupture of membranes bial agents (ampicillin and an aminoglycoside). Once a pathogen is iden- This document is copyrighted and is property of the American tified, antimicrobial therapy should be narrowed (unless synergism is Academy of Pediatrics and its Board of Directors. All authors needed). Recent data suggest an association between prolonged empir- have filed conflict of interest statements with the American ≥ Academy of Pediatrics.
    [Show full text]
  • Neonatal Sepsis 2014.Pdf
    Sepsis in the Newborn Sepsis is the commonest cause of neonatal mortality; it is responsible for about 30-50% of the total neonatal deaths in developing countries.1,2 It is estimated that up to 20% of neonates develop sepsis and approximately 1% die of sepsis related causes.2 Sepsis related mortality is largely preventable with prevention of sepsis itself, timely recognition, rational antimicrobial therapy and aggressive supportive care. Epidemiology: Indian data The incidence of neonatal sepsis according to the data from National Neonatal Perinatal Database (NNPD, 2002-03) is 30 per 1000 live births. The NNPD network comprising of 18 tertiary care neonatal units across India found sepsis to be one of the commonest causes of neonatal mortality contributing to 19% of all neonatal deaths3. Among intramural births, Klebsiella pneumoniae was the most frequently isolated pathogen (32.5%), followed by Staphylococcus aureus (13.6%). Among extramural neonates (referred from community/other hospitals), Klebsiella pneumoniae was again the commonest organism (27%), followed by Staphylococcus aureus (15%) and Pseudomonas (13%).3 Definition Neonatal sepsis is a clinical syndrome characterized by signs and symptoms of infection with or without accompanying bacteremia in the first month of life. It encompasses various systemic infections of the newborn such as septicemia, meningitis, pneumonia, arthritis, osteomyelitis, and urinary tract infections. Superficial infections like conjunctivitis and oral thrush are not usually included under neonatal sepsis. Classification of neonatal sepsis Neonatal sepsis can be classified into two major categories depending up on the onset of symptoms:4 Early onset sepsis (EOS): It presents within the first 72 hours of life.
    [Show full text]
  • A Situational Analysis on Stillbirths, Newborn Deaths and Small and Sick Newborn Care Key Findings from Pakistan - 2019
    A Situational Analysis on Stillbirths, Newborn Deaths and Small and Sick Newborn Care Key Findings from Pakistan - 2019 A Situational Analysis on Stillbirths, Newborn Deaths, and Small & Sick Newborn Care Foreword Over the past two decades, Pakistan has not been able to substantially reduce its neonatal and stillbirth rates. To reduce such a high level of mortality, in addition to safe pregnancy and delivery care, quality of in-patients care for the sick newborn and young infants have to be ensured. Correcting the gaps and addressing the needs in the care of sick infants will immensely help in improving the outcomes of those who are admitted in the hospitals. The Department of Community Health Sciences, Aga Khan University (AKU), embarked on an assessment study to provide the most updated evidence about the inpatient care of Newborn and Young Infants. This work was supported by UNICEF and was done in close collaboration with the Ministry of National Health Services Regulation & Coordination (MNHSR&C) & Health Services Academy, Islamabad. The study conducted a detailed facility assessment, which aimed at assessing the service readiness and quality of in-patient neonatal care. This report presents the situation analysis of existing services and challenges faced in the care of in- patient Newborn and sick young infants. The report also presents views of the key stakeholders about the current health systems response to the needs of in-patient newborn and sick young infants. This work is complemented by a current policy landscape for maternal, neonatal and child health in the country. An attempt has also been made to present some data on the neglected issue of stillbirths, based largely on secondary analysis of available data, in the country supplemented by the perceptions of key stakeholders on the underlying causes of stillbirths in Pakistan.
    [Show full text]